Influenza Vaccine Market

Influenza Vaccine Market (Type: Inactivated and Live Attenuated; Valency: Quadrivalent and Trivalent; Age Group: Pediatric and Adult; Distribution Channel: Hospitals & Pharmacies, Government & Institutional Supply and Other) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2026–2036

Influenza Vaccine Market Outlook 2036

The global influenza vaccine market size was valued at US$ 9.0 Bn in 2025 and is projected to reach US$ 18.5 Bn by 2036, expanding at a CAGR of 6.8% from 2026 to 2036. The market is driven by the rising incidence of seasonal influenza, growing elderly and high-risk population, and strong vaccination guidelines issued by bodies like the World Health Organization. Further growth is supported by government-led immunization programs, increasing public awareness, and higher adoption of quadrivalent vaccines offering broader strain protection.

Market Size & Highlights

The influenza vaccine market reached US$ 9.0 Bn in 2025.
The market is expected to climb to US$ 18.5 Bn by 2036.
The influenza vaccine industry is anticipated to expand at a CAGR of 6.8% from 2026 to 2036.
Major companies in the influenza vaccine market include Pfizer Inc., Sanofi, GSK plc, AstraZeneca, Merck & Co. Inc., Novartis AG, etc.
North America dominated the influenza vaccine market in 2025, holding the largest revenue share of 51.6%
Quadrivalent accounted for the largest market share of 83.4% in 2025

Influenza Vaccine Market By Revenue

Analysts’ Viewpoint

The global influenza vaccines market is witnessing steadiness due to the increasing number of people being infected each year by seasonal flu or an increased number of older adults and people who are at high risk for contracting the virus. Annual vaccine recommendations from the World Health Organization (WHO) also promote vaccination globally and support widespread use of vaccinations each year. The growing number of quadrivalent vaccines (which contain four different kinds of influenza viruses) are bound to provide many options of different kinds of vaccines to help fight seasonal flu and work on a broad range of strains of influenza.

Increasing public awareness of influenza vaccines is bound to contribute to increased use of influenza vaccines over the period of time as well as increased use of government-funded vaccination programs. Pricing pressures on public procurement, inequities in use of vaccinations in low- to middle-income countries, and problems with the production and supply of vaccines using traditional production methods are all likely to inhibit growth in the influenza vaccine market.

However, innovations in technology, including mRNA (a type of messenger RNA) and cell-based vaccine production, have the potential to enable the production of the next generation of influenza vaccines to occur rapidly and effectively. Demand for higher-priced, higher-dose, and adjuvanted (added substances to enhance efficacy) influenza vaccines continue to grow, as do the development of pharmacies and workplaces as vaccination sites, and increasing collaboration between manufacturers to increase the capabilities of the global vaccination supply chain.

Influenza Vaccine Market Introduction

Influenza Vaccine works by helping the immune system learn to fight off a future infection. It does induce an immune response by generating strain-specific antibodies based on yearly recommendations issued by the agencies such as the World Health Organization, thereby reducing the risk of flu-related complications, illnesses, hospitalization, and mortality.

Attribute	Detail
Market Drivers	Rising burden of seasonal influenza and expanding elderly population Government immunization programs and increased uptake of quadrivalent vaccines

Rising Burden of Seasonal Influenza and Expanding Elderly Population Disorders Expected to Drive Influenza Vaccine Market

The increasing incidences of seasonal influenza and the growing elderly population are major drivers of growth of the global influenza vaccine market. Seasonal influenza continues to be a widespread public health concern, wherein it results in millions of infections and sizable hospitalizations worldwide each year.

Frequent viral mutations coupled with the circulation of multiple influenza strains do necessitate yearly vaccination, thereby reinforcing steady demand for influenza vaccines. Global health authorities such as the World Health Organization are strongly recommending routine immunization, especially for high-risk population, which supports consistent vaccine uptake.

Simultaneously, the global population is aging on a rapid note, increasing the number of individuals vulnerable to various influenza outcomes. Elderly people are reported to experience weakened immune responses, which does make them vulnerable to diabetes, cardiovascular disease, and respiratory disorders, thereby significantly elevating the risk of hospitalizations, complications, and mortality. As a result, governments prioritize influenza vaccination for the older adults within national immunization programs.

This demographic shift has also accelerated adoption of high-dose, quadrivalent, and adjuvanted influenza vaccines, which offer wider strain coverage and improved immune protection. Collectively, the growing incidences of influenza disease and expanding geriatric population are expected to sustain long-term demand and support steady growth of the global influenza vaccine market.

Government Immunization Programs and Increased Uptake of Quadrivalent Vaccines Anticipated to Boost Influenza Vaccine Market Expansion

The influenza vaccine market is driven by multiple government immunization programs that provide improved affordability, accessibility, and public awareness of influenza vaccines. Many countries have developed national vaccination programs targeting high-risk population including pregnant women, children, the elderly, and chronically ill individuals. Programs are inclusive of school-based vaccination; free or subsidized vaccines; mass immunization campaigns; and workplace vaccination drives - which all contribute greatly to increasing total vaccination coverage.

Public health authorities and global organizations work jointly to strengthen surveillance systems within their own countries so that procurement and distribution of influenza vaccines occur on time to allow for continuous growth in this market.

Quadrivalent vaccines protect against four strains of the virus (two A and two B), thereby providing more widespread protection as compared to trivalent vaccines. As an outcome, there is a minimal chance of strain mismatch, thus enhancing clinical efficacy of the vaccine and making these vaccines more preferable amongst the patients and healthcare providers alike.

Additional recommendations for quadrivalent influenza vaccines to be added to the national immunization recommendations, and realization of the advantages provided by these vaccines, are also encouraging the use of quadrivalent influenza vaccines.

Attribute	Detail
Market Opportunity	Public-private partnerships for large-scale vaccination campaigns and supply chain strengthening

Public-Private Partnerships for Large-Scale Vaccination Campaigns and Supply Chain Strengthening Presents Significant Opportunity for Influenza Vaccine Market

Partnerships between public and private sector organizations, known as public-private partnerships (PPPs) create significant opportunities for growth within the influenza vaccine market through collaborations across various entities such as government agencies, healthcare providers and pharmaceutical companies.

Collaboratively, the public sector funds the provision and support of policies and healthcare infrastructures, while the private sector provides manufacturing capacity, technology and distribution networks. In this manner, PPPs facilitate greater access and affordability of vaccines in developing or underserved areas through greater availability of vaccines.

By improving cold chain systems, logistics management, and storage facilities, PPPs also have a positive impact on strengthening vaccine supply chains. Improved efficiency, as a result of improved supply chains, reduces the amount of wasted vaccine, results in more timely delivery of vaccines, and ensures that all vaccine products maintain their integrity regardless of where they are located across the globe. In addition, the ability of making bulk purchases and entering into long-term contracts for supplying vaccines through PPPs gives manufacturers the incentive to increase their production capabilities and invest in new technologies for producing vaccines.

Quadrivalent Segment Driving Influenza Vaccine Market Growth

Influenza Vaccine Market By Type

The quadrivalent segment dominates the influenza vaccine industry as it offers the most comprehensive protection and higher clinical effectiveness when compared to the other available options. , Quadrivalent vaccines (filed under "influenza vaccines") comprise four virus strains - two influenza A and two influenza B - which inherently result in higher protection than do trivalent vaccines.

Since quadrivalent vaccines contain more than one strain of any given endemic virus strain, they also tend to have a decreased incidence of mismatch, which ultimately leads to increased efficacy of quadrivalent vaccines based on superior versions having found their way into everyday use by patients and provider.

Additionally, due to the increasing number of seasonal influenza pressures, especially on high-risk groups such as the elderly and children, as well as chronically ill patients, greater demand exists for more effective vaccination strategies. Thus, many countries now recommend quadrivalent influenza vaccines as part of their respective national immunization strategies, which has caused worldwide quadrivalent vaccine adoption rates to increase. Further contributing to the growth of the global quadrivalent market is the general awareness of the advantages of using a quadrivalent formulation among patients and providers.

Pharmaceutical companies have been heavily investing into the research and development activities of quadrivalent vaccines with the help of public and private financial assistance and multiple regulatory approvals.

Regional Outlook of Influenza Vaccine Market

Influenza Vaccine Market By Region

Attribute	Detail
Leading Region	North America

North America is the dominant region in the influenza vaccine market, accounting for a considerable 51.6% market share. This is due to its highly developed health infrastructure, high levels of knowledge about vaccines and vaccination programs, and strong national vaccination policies.

The US and Canada have national vaccination policies that promote the seasonal vaccination of at-risk population (e.g. the elderly, pregnant women, young children, and people with chronic illnesses)

In addition, favorable reimbursement policies, broad availability of healthcare coverage, and increasing levels of healthcare spending enable the uptake of vaccines by those that need to be vaccinated. Overall, North America benefits from strong government regulations, advanced technologies, and high levels of immunization.

Analysis of Key Players in Influenza Vaccine Market

Pfizer Inc., Sanofi, GSK plc, AstraZeneca, Merck & Co. Inc., Novartis AG, F. Hoffmann-La Roche Ltd, CSL, Johnson & Johnson and its affiliates, DAIICHI SANKYO COMPANY, LIMITED, Bharat Biotech, SINOVAC, KM Biologics, Takeda Pharmaceutical Company Limited are the key players governing the global Influenza Vaccine Market.

Each of these players has been profiled in the influenza vaccine market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Key Developments

In January 2026, Moderna, Inc. provided an update on regulatory submissions for its investigational seasonal influenza vaccine, mRNA-1010, for adults aged 50 years and older.
In August 2025, AstraZeneca launched FluMist Home, the first-of-its-kind, at-home delivery service for FLUMIST (Influenza Vaccine Live, Intranasal). FLUMIST is the first and only seasonal influenza vaccine approved to be self-administered by adults 18 to 49 years of age or administered by a parent or caregiver to individuals aged 2-17.
In April 2025, Arcturus Therapeutics Holdings Inc. announced that the U.S. Food and Drug Administration (FDA) had granted Fast Track Designation for the self-amplifying mRNA (sa-mRNA) vaccine candidate called ARCT-2304 designed for active immunization for protecting against disease caused by influenza A H5N1 subtype contained in the vaccine.

Influenza Vaccine Market Snapshot

Attribute	Detail
Size in 2025	US$ 9.0 Bn
Forecast Value in 2036	More than US$ 18.5 Bn
CAGR	6.8%
Forecast Period	2026-2036
Historical Data Available for	2020-2024
Quantitative Units	US$ Bn for Value
Market Analysis	It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis.
Competition Landscape	Competition Matrix Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format	Electronic (PDF) + Excel
Segmentation	Type Inactivated Live Attenuated Valency Quadrivalent Trivalent Age Group Pediatric Adult Route of Administration Injection Nasal Spray Distribution Channel Hospitals & Pharmacies Government & Institutional Supply Other
Regions Covered	North America Europe Asia Pacific Latin America Middle East & Africa
Countries Covered	U.S. Canada Germany U.K. France Italy Spain The Netherlands China India Japan South Korea Australia ASEAN Brazil Mexico Argentina GCC Countries South Africa
Companies Profiled	Pfizer Inc. Sanofi GSK plc. AstraZeneca Merck & Co. Inc. Novartis AG F. Hoffmann-La Roche Ltd CSL Johnson & Johnson and its affiliates DAIICHI SANKYO COMPANY, LIMITED Bharat Biotech SINOVAC KM Biologics Takeda Pharmaceutical Company Limited Other Prominent Players
Customization Scope	Available upon request
Pricing	Available upon request

Frequently Asked Questions

How big was the global influenza vaccine market in 2025?

The global influenza vaccine market was valued at US$ 9.0 Bn in 2025

What is the projected size of the influenza vaccine industry by 2036?

The global influenza vaccine market is projected to cross US$ 18.5 Bn by the end of 2036

What are the factors driving the influenza vaccine market?

Rising burden of seasonal influenza and expanding elderly population and Government immunization programs and increased uptake of quadrivalent vaccines

What is the influenza vaccine market expected to grow during the forecast period?

The global influenza vaccine market is anticipated to grow at a CAGR 6.8% from 2026 to 2036

Which region is expected to dominate the influenza vaccine market during the forecast period?

North America is expected to account for the largest share from 2026 to 2036

Who are the prominent influenza vaccine providers?

Pfizer Inc., Sanofi, GSK plc., AstraZeneca, Merck & Co. Inc., Novartis AG, F. Hoffmann-La Roche Ltd, CSL, Johnson & Johnson and its affiliates, DAIICHI SANKYO COMPANY, LIMITED, Bharat Biotech, SINOVAC, KM Biologics, Takeda Pharmaceutical Company Limited, and other prominent players

Preface
- Market Definition and Scope
- Market Segmentation
- Key Research Objectives
- Research Highlights
Assumptions and Research Methodology
Executive Summary: Global Influenza Vaccine Market
Market Overview
- Introduction
  - Segment Definition
  - Industry Evolution / Developments
- Overview
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunities
- Global Influenza Vaccine Market Analysis and Forecast, 2021-2036
  - Market Revenue Projections (US$ Bn)
Key Insights
- Healthcare Expenditure by Country/Region
- Recent Technological Advancements
- Regulatory Scenario across Key Countries / Regions
- PORTER’s Five Forces Analysis
- Consumer Behavior & End-User Insights
- PESTLE Analysis
- Key Industry Events
- Pricing Analysis
- Regulatory Landscape across Key Regions / Countries
- Go to Marketing Strategies for New Entrants
- Supply Chain Analysis
Global Influenza Vaccine Market Analysis and Forecast, by Type
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Type, 2021-2036
  - Inactivated
  - Live Attenuated
- Market Attractiveness Analysis, by Type
Global Influenza Vaccine Market Analysis and Forecast, by Valency
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Valency, 2021-2036
  - Quadrivalent
  - Trivalent
- Market Attractiveness Analysis, by Valency
Global Influenza Vaccine Market Analysis and Forecast, by Age Group
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Age Group, 2021-2036
  - Pediatric
  - Adult
- Market Attractiveness Analysis, by Age Group
Global Influenza Vaccine Market Analysis and Forecast, by Route of Administration
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Route of Administration, 2021-2036
  - Injection
  - Nasal Spray
- Market Attractiveness Analysis, by Route of Administration
Global Influenza Vaccine Market Analysis and Forecast, by Distribution Channel
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospitals & Pharmacies
  - Government & Institutional Supply
  - Others
- Market Attractiveness Analysis, by Distribution Channel
Global Influenza Vaccine Market Analysis and Forecast, by Region
- Key Findings
- Market Value Forecast, by Region, 2021-2036
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East & Africa
- Market Attractiveness Analysis, by Region
North America Influenza Vaccine Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Type, 2021-2036
  - Inactivated
  - Live Attenuated
- Market Value Forecast, by Valency, 2021-2036
  - Quadrivalent
  - Trivalent
- Market Value Forecast, by Age Group, 2021-2036
  - Pediatric
  - Adult
- Market Value Forecast, by Route of Administration, 2021-2036
  - Injection
  - Nasal Spray
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospitals & Pharmacies
  - Government & Institutional Supply
  - Others
- Market Value Forecast, by Country, 2021-2036
  - U.S.
  - Canada
- Market Attractiveness Analysis
  - By Type
  - By Valency
  - By Age Group
  - By Route of Administration
  - By Distribution Channel
  - By Country
U.S. Influenza Vaccine Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Type, 2021-2036
  - Inactivated
  - Live Attenuated
- Market Value Forecast, by Valency, 2021-2036
  - Quadrivalent
  - Trivalent
- Market Value Forecast, by Age Group, 2021-2036
  - Pediatric
  - Adult
- Market Value Forecast, by Route of Administration, 2021-2036
  - Injection
  - Nasal Spray
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospitals & Pharmacies
  - Government & Institutional Supply
  - Others
- Market Attractiveness Analysis
  - By Type
  - By Valency
  - By Age Group
  - By Route of Administration
  - By Distribution Channel
Canada Influenza Vaccine Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Type, 2021-2036
  - Inactivated
  - Live Attenuated
- Market Value Forecast, by Valency, 2021-2036
  - Quadrivalent
  - Trivalent
- Market Value Forecast, by Age Group, 2021-2036
  - Pediatric
  - Adult
- Market Value Forecast, by Route of Administration, 2021-2036
  - Injection
  - Nasal Spray
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospitals & Pharmacies
  - Government & Institutional Supply
  - Others
- Market Attractiveness Analysis
  - By Type
  - By Valency
  - By Age Group
  - By Route of Administration
  - By Distribution Channel
Europe Influenza Vaccine Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Type, 2021-2036
  - Inactivated
  - Live Attenuated
- Market Value Forecast, by Valency, 2021-2036
  - Quadrivalent
  - Trivalent
- Market Value Forecast, by Age Group, 2021-2036
  - Pediatric
  - Adult
- Market Value Forecast, by Route of Administration, 2021-2036
  - Injection
  - Nasal Spray
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospitals & Pharmacies
  - Government & Institutional Supply
  - Others
- Market Value Forecast, by Country/Sub-region, 2021-2036
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - The Netherlands
  - Rest of Europe
- Market Attractiveness Analysis
  - By Type
  - By Valency
  - By Age Group
  - By Route of Administration
  - By Distribution Channel
  - By Country/Sub-region
Germany Influenza Vaccine Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Type, 2021-2036
  - Inactivated
  - Live Attenuated
- Market Value Forecast, by Valency, 2021-2036
  - Quadrivalent
  - Trivalent
- Market Value Forecast, by Age Group, 2021-2036
  - Pediatric
  - Adult
- Market Value Forecast, by Route of Administration, 2021-2036
  - Injection
  - Nasal Spray
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospitals & Pharmacies
  - Government & Institutional Supply
  - Others
- Market Attractiveness Analysis
  - By Type
  - By Valency
  - By Age Group
  - By Route of Administration
  - By Distribution Channel
U.K. Influenza Vaccine Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Type, 2021-2036
  - Inactivated
  - Live Attenuated
- Market Value Forecast, by Valency, 2021-2036
  - Quadrivalent
  - Trivalent
- Market Value Forecast, by Age Group, 2021-2036
  - Pediatric
  - Adult
- Market Value Forecast, by Route of Administration, 2021-2036
  - Injection
  - Nasal Spray
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospitals & Pharmacies
  - Government & Institutional Supply
  - Others
- Market Attractiveness Analysis
  - By Type
  - By Valency
  - By Age Group
  - By Route of Administration
  - By Distribution Channel
France Influenza Vaccine Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Type, 2021-2036
  - Inactivated
  - Live Attenuated
- Market Value Forecast, by Valency, 2021-2036
  - Quadrivalent
  - Trivalent
- Market Value Forecast, by Age Group, 2021-2036
  - Pediatric
  - Adult
- Market Value Forecast, by Route of Administration, 2021-2036
  - Injection
  - Nasal Spray
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospitals & Pharmacies
  - Government & Institutional Supply
  - Others
- Market Attractiveness Analysis
  - By Type
  - By Valency
  - By Age Group
  - By Route of Administration
  - By Distribution Channel
Italy Influenza Vaccine Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Type, 2021-2036
  - Inactivated
  - Live Attenuated
- Market Value Forecast, by Valency, 2021-2036
  - Quadrivalent
  - Trivalent
- Market Value Forecast, by Age Group, 2021-2036
  - Pediatric
  - Adult
- Market Value Forecast, by Route of Administration, 2021-2036
  - Injection
  - Nasal Spray
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospitals & Pharmacies
  - Government & Institutional Supply
  - Others
- Market Attractiveness Analysis
  - By Type
  - By Valency
  - By Age Group
  - By Route of Administration
  - By Distribution Channel
Spain Influenza Vaccine Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Type, 2021-2036
  - Inactivated
  - Live Attenuated
- Market Value Forecast, by Valency, 2021-2036
  - Quadrivalent
  - Trivalent
- Market Value Forecast, by Age Group, 2021-2036
  - Pediatric
  - Adult
- Market Value Forecast, by Route of Administration, 2021-2036
  - Injection
  - Nasal Spray
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospitals & Pharmacies
  - Government & Institutional Supply
  - Others
- Market Attractiveness Analysis
  - By Type
  - By Valency
  - By Age Group
  - By Route of Administration
  - By Distribution Channel
The Netherlands Influenza Vaccine Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Type, 2021-2036
  - Inactivated
  - Live Attenuated
- Market Value Forecast, by Valency, 2021-2036
  - Quadrivalent
  - Trivalent
- Market Value Forecast, by Age Group, 2021-2036
  - Pediatric
  - Adult
- Market Value Forecast, by Route of Administration, 2021-2036
  - Injection
  - Nasal Spray
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospitals & Pharmacies
  - Government & Institutional Supply
  - Others
- Market Attractiveness Analysis
  - By Type
  - By Valency
  - By Age Group
  - By Route of Administration
  - By Distribution Channel
Rest of Europe Influenza Vaccine Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Type, 2021-2036
  - Inactivated
  - Live Attenuated
- Market Value Forecast, by Valency, 2021-2036
  - Quadrivalent
  - Trivalent
- Market Value Forecast, by Age Group, 2021-2036
  - Pediatric
  - Adult
- Market Value Forecast, by Route of Administration, 2021-2036
  - Injection
  - Nasal Spray
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospitals & Pharmacies
  - Government & Institutional Supply
  - Others
- Market Attractiveness Analysis
  - By Type
  - By Valency
  - By Age Group
  - By Route of Administration
  - By Distribution Channel
Asia Pacific Influenza Vaccine Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Type, 2021-2036
  - Inactivated
  - Live Attenuated
- Market Value Forecast, by Valency, 2021-2036
  - Quadrivalent
  - Trivalent
- Market Value Forecast, by Age Group, 2021-2036
  - Pediatric
  - Adult
- Market Value Forecast, by Route of Administration, 2021-2036
  - Injection
  - Nasal Spray
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospitals & Pharmacies
  - Government & Institutional Supply
  - Others
- Market Value Forecast, by Country/Sub-region, 2021-2036
  - China
  - India
  - Japan
  - South Korea
  - Australia
  - ASEAN
  - Rest of Asia Pacific
- Market Attractiveness Analysis
  - By Type
  - By Valency
  - By Age Group
  - By Route of Administration
  - By Distribution Channel
  - By Country/Sub-region
China Influenza Vaccine Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Type, 2021-2036
  - Inactivated
  - Live Attenuated
- Market Value Forecast, by Valency, 2021-2036
  - Quadrivalent
  - Trivalent
- Market Value Forecast, by Age Group, 2021-2036
  - Pediatric
  - Adult
- Market Value Forecast, by Route of Administration, 2021-2036
  - Injection
  - Nasal Spray
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospitals & Pharmacies
  - Government & Institutional Supply
  - Others
- Market Attractiveness Analysis
  - By Type
  - By Valency
  - By Age Group
  - By Route of Administration
  - By Distribution Channel
India Influenza Vaccine Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Type, 2021-2036
  - Inactivated
  - Live Attenuated
- Market Value Forecast, by Valency, 2021-2036
  - Quadrivalent
  - Trivalent
- Market Value Forecast, by Age Group, 2021-2036
  - Pediatric
  - Adult
- Market Value Forecast, by Route of Administration, 2021-2036
  - Injection
  - Nasal Spray
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospitals & Pharmacies
  - Government & Institutional Supply
  - Others
- Market Attractiveness Analysis
  - By Type
  - By Valency
  - By Age Group
  - By Route of Administration
  - By Distribution Channel
Japan Influenza Vaccine Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Type, 2021-2036
  - Inactivated
  - Live Attenuated
- Market Value Forecast, by Valency, 2021-2036
  - Quadrivalent
  - Trivalent
- Market Value Forecast, by Age Group, 2021-2036
  - Pediatric
  - Adult
- Market Value Forecast, by Route of Administration, 2021-2036
  - Injection
  - Nasal Spray
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospitals & Pharmacies
  - Government & Institutional Supply
  - Others
- Market Attractiveness Analysis
  - By Type
  - By Valency
  - By Age Group
  - By Route of Administration
  - By Distribution Channel
South Korea Influenza Vaccine Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Type, 2021-2036
  - Inactivated
  - Live Attenuated
- Market Value Forecast, by Valency, 2021-2036
  - Quadrivalent
  - Trivalent
- Market Value Forecast, by Age Group, 2021-2036
  - Pediatric
  - Adult
- Market Value Forecast, by Route of Administration, 2021-2036
  - Injection
  - Nasal Spray
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospitals & Pharmacies
  - Government & Institutional Supply
  - Others
- Market Attractiveness Analysis
  - By Type
  - By Valency
  - By Age Group
  - By Route of Administration
  - By Distribution Channel
Australia Influenza Vaccine Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Type, 2021-2036
  - Inactivated
  - Live Attenuated
- Market Value Forecast, by Valency, 2021-2036
  - Quadrivalent
  - Trivalent
- Market Value Forecast, by Age Group, 2021-2036
  - Pediatric
  - Adult
- Market Value Forecast, by Route of Administration, 2021-2036
  - Injection
  - Nasal Spray
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospitals & Pharmacies
  - Government & Institutional Supply
  - Others
- Market Attractiveness Analysis
  - By Type
  - By Valency
  - By Age Group
  - By Route of Administration
  - By Distribution Channel
ASEAN Influenza Vaccine Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Type, 2021-2036
  - Inactivated
  - Live Attenuated
- Market Value Forecast, by Valency, 2021-2036
  - Quadrivalent
  - Trivalent
- Market Value Forecast, by Age Group, 2021-2036
  - Pediatric
  - Adult
- Market Value Forecast, by Route of Administration, 2021-2036
  - Injection
  - Nasal Spray
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospitals & Pharmacies
  - Government & Institutional Supply
  - Others
- Market Attractiveness Analysis
  - By Type
  - By Valency
  - By Age Group
  - By Route of Administration
  - By Distribution Channel
Rest of Asia Pacific Influenza Vaccine Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Type, 2021-2036
  - Inactivated
  - Live Attenuated
- Market Value Forecast, by Valency, 2021-2036
  - Quadrivalent
  - Trivalent
- Market Value Forecast, by Age Group, 2021-2036
  - Pediatric
  - Adult
- Market Value Forecast, by Route of Administration, 2021-2036
  - Injection
  - Nasal Spray
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospitals & Pharmacies
  - Government & Institutional Supply
  - Others
- Market Attractiveness Analysis
  - By Type
  - By Valency
  - By Age Group
  - By Route of Administration
  - By Distribution Channel
Latin America Influenza Vaccine Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Type, 2021-2036
  - Inactivated
  - Live Attenuated
- Market Value Forecast, by Valency, 2021-2036
  - Quadrivalent
  - Trivalent
- Market Value Forecast, by Age Group, 2021-2036
  - Pediatric
  - Adult
- Market Value Forecast, by Route of Administration, 2021-2036
  - Injection
  - Nasal Spray
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospitals & Pharmacies
  - Government & Institutional Supply
  - Others
- Market Value Forecast, by Country/Sub-region, 2021-2036
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Market Attractiveness Analysis
  - By Type
  - By Valency
  - By Age Group
  - By Route of Administration
  - By Distribution Channel
  - By Country/Sub-region
Brazil Influenza Vaccine Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Type, 2021-2036
  - Inactivated
  - Live Attenuated
- Market Value Forecast, by Valency, 2021-2036
  - Quadrivalent
  - Trivalent
- Market Value Forecast, by Age Group, 2021-2036
  - Pediatric
  - Adult
- Market Value Forecast, by Route of Administration, 2021-2036
  - Injection
  - Nasal Spray
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospitals & Pharmacies
  - Government & Institutional Supply
  - Others
- Market Attractiveness Analysis
  - By Type
  - By Valency
  - By Age Group
  - By Route of Administration
  - By Distribution Channel
Mexico Influenza Vaccine Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Type, 2021-2036
  - Inactivated
  - Live Attenuated
- Market Value Forecast, by Valency, 2021-2036
  - Quadrivalent
  - Trivalent
- Market Value Forecast, by Age Group, 2021-2036
  - Pediatric
  - Adult
- Market Value Forecast, by Route of Administration, 2021-2036
  - Injection
  - Nasal Spray
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospitals & Pharmacies
  - Government & Institutional Supply
  - Others
- Market Attractiveness Analysis
  - By Type
  - By Valency
  - By Age Group
  - By Route of Administration
  - By Distribution Channel
Argentina Influenza Vaccine Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Type, 2021-2036
  - Inactivated
  - Live Attenuated
- Market Value Forecast, by Valency, 2021-2036
  - Quadrivalent
  - Trivalent
- Market Value Forecast, by Age Group, 2021-2036
  - Pediatric
  - Adult
- Market Value Forecast, by Route of Administration, 2021-2036
  - Injection
  - Nasal Spray
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospitals & Pharmacies
  - Government & Institutional Supply
  - Others
- Market Attractiveness Analysis
  - By Type
  - By Valency
  - By Age Group
  - By Route of Administration
  - By Distribution Channel
Rest of Latin America Influenza Vaccine Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Type, 2021-2036
  - Inactivated
  - Live Attenuated
- Market Value Forecast, by Valency, 2021-2036
  - Quadrivalent
  - Trivalent
- Market Value Forecast, by Age Group, 2021-2036
  - Pediatric
  - Adult
- Market Value Forecast, by Route of Administration, 2021-2036
  - Injection
  - Nasal Spray
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospitals & Pharmacies
  - Government & Institutional Supply
  - Others
- Market Attractiveness Analysis
  - By Type
  - By Valency
  - By Age Group
  - By Route of Administration
  - By Distribution Channel
Middle East & Africa Influenza Vaccine Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Type, 2021-2036
  - Inactivated
  - Live Attenuated
- Market Value Forecast, by Valency, 2021-2036
  - Quadrivalent
  - Trivalent
- Market Value Forecast, by Age Group, 2021-2036
  - Pediatric
  - Adult
- Market Value Forecast, by Route of Administration, 2021-2036
  - Injection
  - Nasal Spray
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospitals & Pharmacies
  - Government & Institutional Supply
  - Others
- Market Value Forecast, by Country/Sub-region, 2021-2036
  - GCC Countries
  - South Africa
  - Rest of Middle East & Africa
- Market Attractiveness Analysis
  - By Type
  - By Valency
  - By Age Group
  - By Route of Administration
  - By Distribution Channel
  - By Country/Sub-region
GCC Countries Influenza Vaccine Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Type, 2021-2036
  - Inactivated
  - Live Attenuated
- Market Value Forecast, by Valency, 2021-2036
  - Quadrivalent
  - Trivalent
- Market Value Forecast, by Age Group, 2021-2036
  - Pediatric
  - Adult
- Market Value Forecast, by Route of Administration, 2021-2036
  - Injection
  - Nasal Spray
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospitals & Pharmacies
  - Government & Institutional Supply
  - Others
- Market Attractiveness Analysis
  - By Type
  - By Valency
  - By Age Group
  - By Route of Administration
  - By Distribution Channel
South Africa Influenza Vaccine Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Type, 2021-2036
  - Inactivated
  - Live Attenuated
- Market Value Forecast, by Valency, 2021-2036
  - Quadrivalent
  - Trivalent
- Market Value Forecast, by Age Group, 2021-2036
  - Pediatric
  - Adult
- Market Value Forecast, by Route of Administration, 2021-2036
  - Injection
  - Nasal Spray
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospitals & Pharmacies
  - Government & Institutional Supply
  - Others
- Market Attractiveness Analysis
  - By Type
  - By Valency
  - By Age Group
  - By Route of Administration
  - By Distribution Channel
Rest of Middle East & Africa Influenza Vaccine Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Type, 2021-2036
  - Inactivated
  - Live Attenuated
- Market Value Forecast, by Valency, 2021-2036
  - Quadrivalent
  - Trivalent
- Market Value Forecast, by Age Group, 2021-2036
  - Pediatric
  - Adult
- Market Value Forecast, by Route of Administration, 2021-2036
  - Injection
  - Nasal Spray
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospitals & Pharmacies
  - Government & Institutional Supply
  - Others
- Market Attractiveness Analysis
  - By Type
  - By Valency
  - By Age Group
  - By Route of Administration
  - By Distribution Channel
Competition Landscape
- Market Player - Competition Matrix (By Tier and Size of Companies)
- Market Share Analysis, by Company (2024)
- Company Profiles
  - Pfizer Inc.
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Sanofi
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - GSK plc.
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - AstraZeneca
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Merck & Co. Inc.
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Novartis AG
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - F. Hoffmann-La Roche Ltd
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - CSL
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Johnson & Johnson and its affiliates
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - DAIICHI SANKYO COMPANY, LIMITED
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Bharat Biotech
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - SINOVAC
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - KM Biologics
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Takeda Pharmaceutical Company Limited
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Other Prominent Players

List of Tables

Table 01: Global Influenza Vaccine Market Value (US$ Bn) Forecast, by Type, 2021 to 2036
Table 02: Global Influenza Vaccine Market Value (US$ Bn) Forecast, by Valency, 2021 to 2036
Table 03: Global Influenza Vaccine Market Value (US$ Bn) Forecast, by Age Group, 2021 to 2036
Table 04: Global Influenza Vaccine Market Value (US$ Bn) Forecast, by Route of Administration, 2021 to 2036
Table 05: Global Influenza Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2021 to 2036
Table 06: Global Influenza Vaccine Market Value (US$ Bn) Forecast, by Country/Sub-region, 2021 to 2036
Table 07: North America Influenza Vaccine Market Value (US$ Bn) Forecast, by Type, 2021 to 2036
Table 08: North America Influenza Vaccine Market Value (US$ Bn) Forecast, by Valency, 2021 to 2036
Table 09: North America Influenza Vaccine Market Value (US$ Bn) Forecast, by Age Group, 2021 to 2036
Table 10: North America Influenza Vaccine Market Value (US$ Bn) Forecast, by Route of Administration, 2021 to 2036
Table 11: North America Influenza Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2021 to 2036
Table 12: North America Influenza Vaccine Market Value (US$ Bn) Forecast, by Country/Sub-region, 2021 to 2036
Table 13: U.S. Influenza Vaccine Market Value (US$ Bn) Forecast, by Type, 2021 to 2036
Table 14: U.S. Influenza Vaccine Market Value (US$ Bn) Forecast, by Valency, 2021 to 2036
Table 15: U.S. Influenza Vaccine Market Value (US$ Bn) Forecast, by Age Group, 2021 to 2036
Table 16: U.S. Influenza Vaccine Market Value (US$ Bn) Forecast, by Route of Administration, 2021 to 2036
Table 17: U.S. Influenza Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2021 to 2036
Table 18: Canada Influenza Vaccine Market Value (US$ Bn) Forecast, by Type, 2021 to 2036
Table 19: Canada Influenza Vaccine Market Value (US$ Bn) Forecast, by Valency, 2021 to 2036
Table 20: Canada Influenza Vaccine Market Value (US$ Bn) Forecast, by Age Group, 2021 to 2036
Table 21: Canada Influenza Vaccine Market Value (US$ Bn) Forecast, by Route of Administration, 2021 to 2036
Table 22: Canada Influenza Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2021 to 2036
Table 23: Europe Influenza Vaccine Market Value (US$ Bn) Forecast, by Type, 2021 to 2036
Table 24: Europe Influenza Vaccine Market Value (US$ Bn) Forecast, by Valency, 2021 to 2036
Table 25: Europe Influenza Vaccine Market Value (US$ Bn) Forecast, by Age Group, 2021 to 2036
Table 26: Europe Influenza Vaccine Market Value (US$ Bn) Forecast, by Route of Administration, 2021 to 2036
Table 27: Europe Influenza Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2021 to 2036
Table 28: Europe Influenza Vaccine Market Value (US$ Bn) Forecast, by Country/Sub-region, 2021 to 2036
Table 29: Germany Influenza Vaccine Market Value (US$ Bn) Forecast, by Type, 2021 to 2036
Table 30: Germany Influenza Vaccine Market Value (US$ Bn) Forecast, by Valency, 2021 to 2036
Table 31: Germany Influenza Vaccine Market Value (US$ Bn) Forecast, by Age Group, 2021 to 2036
Table 32: Germany Influenza Vaccine Market Value (US$ Bn) Forecast, by Route of Administration, 2021 to 2036
Table 33: Germany Influenza Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2021 to 2036
Table 34: U.K. Influenza Vaccine Market Value (US$ Bn) Forecast, by Type, 2021 to 2036
Table 35: U.K. Influenza Vaccine Market Value (US$ Bn) Forecast, by Valency, 2021 to 2036
Table 36: U.K. Influenza Vaccine Market Value (US$ Bn) Forecast, by Age Group, 2021 to 2036
Table 37: U.K. Influenza Vaccine Market Value (US$ Bn) Forecast, by Route of Administration, 2021 to 2036
Table 38: U.K. Influenza Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2021 to 2036
Table 39: France Influenza Vaccine Market Value (US$ Bn) Forecast, by Type, 2021 to 2036
Table 40: France Influenza Vaccine Market Value (US$ Bn) Forecast, by Valency, 2021 to 2036
Table 41: France Influenza Vaccine Market Value (US$ Bn) Forecast, by Age Group, 2021 to 2036
Table 42: France Influenza Vaccine Market Value (US$ Bn) Forecast, by Route of Administration, 2021 to 2036
Table 43: France Influenza Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2021 to 2036
Table 44: Italy Influenza Vaccine Market Value (US$ Bn) Forecast, by Type, 2021 to 2036
Table 45: Italy Influenza Vaccine Market Value (US$ Bn) Forecast, by Valency, 2021 to 2036
Table 46: Italy Influenza Vaccine Market Value (US$ Bn) Forecast, by Age Group, 2021 to 2036
Table 47: Italy Influenza Vaccine Market Value (US$ Bn) Forecast, by Route of Administration, 2021 to 2036
Table 48: Italy Influenza Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2021 to 2036
Table 49: Spain Influenza Vaccine Market Value (US$ Bn) Forecast, by Type, 2021 to 2036
Table 50: Spain Influenza Vaccine Market Value (US$ Bn) Forecast, by Valency, 2021 to 2036
Table 51: Spain Influenza Vaccine Market Value (US$ Bn) Forecast, by Age Group, 2021 to 2036
Table 52: Spain Influenza Vaccine Market Value (US$ Bn) Forecast, by Route of Administration, 2021 to 2036
Table 53: Spain Influenza Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2021 to 2036
Table 54: The Netherlands Influenza Vaccine Market Value (US$ Bn) Forecast, by Type, 2021 to 2036
Table 55: The Netherlands Influenza Vaccine Market Value (US$ Bn) Forecast, by Valency, 2021 to 2036
Table 56: The Netherlands Influenza Vaccine Market Value (US$ Bn) Forecast, by Age Group, 2021 to 2036
Table 57: The Netherlands Influenza Vaccine Market Value (US$ Bn) Forecast, by Route of Administration, 2021 to 2036
Table 58: The Netherlands Influenza Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2021 to 2036
Table 59: Rest of Europe Influenza Vaccine Market Value (US$ Bn) Forecast, by Type, 2021 to 2036
Table 60: Rest of Europe Influenza Vaccine Market Value (US$ Bn) Forecast, by Valency, 2021 to 2036
Table 61: Rest of Europe Influenza Vaccine Market Value (US$ Bn) Forecast, by Age Group, 2021 to 2036
Table 62: Rest of Europe Influenza Vaccine Market Value (US$ Bn) Forecast, by Route of Administration, 2021 to 2036
Table 63: Rest of Europe Influenza Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2021 to 2036
Table 64: Asia Pacific Influenza Vaccine Market Value (US$ Bn) Forecast, by Type, 2021 to 2036
Table 65: Asia Pacific Influenza Vaccine Market Value (US$ Bn) Forecast, by Valency, 2021 to 2036
Table 66: Asia Pacific Influenza Vaccine Market Value (US$ Bn) Forecast, by Age Group, 2021 to 2036
Table 67: Asia Pacific Influenza Vaccine Market Value (US$ Bn) Forecast, by Route of Administration, 2021 to 2036
Table 68: Asia Pacific Influenza Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2021 to 2036
Table 69: Asia Pacific Influenza Vaccine Market Value (US$ Bn) Forecast, by Country/Sub-region, 2021 to 2036
Table 70: China Influenza Vaccine Market Value (US$ Bn) Forecast, by Type, 2021 to 2036
Table 71: China Influenza Vaccine Market Value (US$ Bn) Forecast, by Valency, 2021 to 2036
Table 72: China Influenza Vaccine Market Value (US$ Bn) Forecast, by Age Group, 2021 to 2036
Table 73: China Influenza Vaccine Market Value (US$ Bn) Forecast, by Route of Administration, 2021 to 2036
Table 74: China Influenza Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2021 to 2036
Table 75: Japan Influenza Vaccine Market Value (US$ Bn) Forecast, by Type, 2021 to 2036
Table 76: Japan Influenza Vaccine Market Value (US$ Bn) Forecast, by Valency, 2021 to 2036
Table 77: Japan Influenza Vaccine Market Value (US$ Bn) Forecast, by Age Group, 2021 to 2036
Table 78: Japan Influenza Vaccine Market Value (US$ Bn) Forecast, by Route of Administration, 2021 to 2036
Table 79: Japan Influenza Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2021 to 2036
Table 80: India Influenza Vaccine Market Value (US$ Bn) Forecast, by Type, 2021 to 2036
Table 81: India Influenza Vaccine Market Value (US$ Bn) Forecast, by Valency, 2021 to 2036
Table 82: India Influenza Vaccine Market Value (US$ Bn) Forecast, by Age Group, 2021 to 2036
Table 83: India Influenza Vaccine Market Value (US$ Bn) Forecast, by Route of Administration, 2021 to 2036
Table 84: India Influenza Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2021 to 2036
Table 85: South Korea Influenza Vaccine Market Value (US$ Bn) Forecast, by Type, 2021 to 2036
Table 86: South Korea Influenza Vaccine Market Value (US$ Bn) Forecast, by Valency, 2021 to 2036
Table 87: South Korea Influenza Vaccine Market Value (US$ Bn) Forecast, by Age Group, 2021 to 2036
Table 88: South Korea Influenza Vaccine Market Value (US$ Bn) Forecast, by Route of Administration, 2021 to 2036
Table 89: South Korea Influenza Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2021 to 2036
Table 90: Australia Influenza Vaccine Market Value (US$ Bn) Forecast, by Type, 2021 to 2036
Table 91: Australia Influenza Vaccine Market Value (US$ Bn) Forecast, by Valency, 2021 to 2036
Table 92: Australia Influenza Vaccine Market Value (US$ Bn) Forecast, by Age Group, 2021 to 2036
Table 93: Australia Influenza Vaccine Market Value (US$ Bn) Forecast, by Route of Administration, 2021 to 2036
Table 94: Australia Influenza Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2021 to 2036
Table 95: ASEAN Influenza Vaccine Market Value (US$ Bn) Forecast, by Type, 2021 to 2036
Table 96: ASEAN Influenza Vaccine Market Value (US$ Bn) Forecast, by Valency, 2021 to 2036
Table 97: ASEAN Influenza Vaccine Market Value (US$ Bn) Forecast, by Age Group, 2021 to 2036
Table 98: ASEAN Influenza Vaccine Market Value (US$ Bn) Forecast, by Route of Administration, 2021 to 2036
Table 99: ASEAN Influenza Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2021 to 2036
Table 100: Rest of Asia Pacific Influenza Vaccine Market Value (US$ Bn) Forecast, by Type, 2021 to 2036
Table 101: Rest of Asia Pacific Influenza Vaccine Market Value (US$ Bn) Forecast, by Valency, 2021 to 2036
Table 102: Rest of Asia Pacific Influenza Vaccine Market Value (US$ Bn) Forecast, by Age Group, 2021 to 2036
Table 103: Rest of Asia Pacific Influenza Vaccine Market Value (US$ Bn) Forecast, by Route of Administration, 2021 to 2036
Table 104: Rest of Asia Pacific Influenza Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2021 to 2036
Table 105: Latin America Influenza Vaccine Market Value (US$ Bn) Forecast, by Type, 2021 to 2036
Table 106: Latin America Influenza Vaccine Market Value (US$ Bn) Forecast, by Valency, 2021 to 2036
Table 107: Latin America Influenza Vaccine Market Value (US$ Bn) Forecast, by Age Group, 2021 to 2036
Table 108: Latin America Influenza Vaccine Market Value (US$ Bn) Forecast, by Route of Administration, 2021 to 2036
Table 109: Latin America Influenza Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2021 to 2036
Table 110: Latin America Influenza Vaccine Market Value (US$ Bn) Forecast, by Country/Sub-region, 2021 to 2036
Table 111: Brazil Influenza Vaccine Market Value (US$ Bn) Forecast, by Type, 2021 to 2036
Table 112: Brazil Influenza Vaccine Market Value (US$ Bn) Forecast, by Valency, 2021 to 2036
Table 113: Brazil Influenza Vaccine Market Value (US$ Bn) Forecast, by Age Group, 2021 to 2036
Table 114: Brazil Influenza Vaccine Market Value (US$ Bn) Forecast, by Route of Administration, 2021 to 2036
Table 115: Brazil Influenza Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2021 to 2036
Table 116: Mexico Influenza Vaccine Market Value (US$ Bn) Forecast, by Type, 2021 to 2036
Table 117: Mexico Influenza Vaccine Market Value (US$ Bn) Forecast, by Valency, 2021 to 2036
Table 118: Mexico Influenza Vaccine Market Value (US$ Bn) Forecast, by Age Group, 2021 to 2036
Table 119: Mexico Influenza Vaccine Market Value (US$ Bn) Forecast, by Route of Administration, 2021 to 2036
Table 120: Mexico Influenza Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2021 to 2036
Table 121: Argentina Influenza Vaccine Market Value (US$ Bn) Forecast, by Type, 2021 to 2036
Table 122: Argentina Influenza Vaccine Market Value (US$ Bn) Forecast, by Valency, 2021 to 2036
Table 123: Argentina Influenza Vaccine Market Value (US$ Bn) Forecast, by Age Group, 2021 to 2036
Table 124: Argentina Influenza Vaccine Market Value (US$ Bn) Forecast, by Route of Administration, 2021 to 2036
Table 125: Argentina Influenza Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2021 to 2036
Table 126: Rest of Latin America Influenza Vaccine Market Value (US$ Bn) Forecast, by Type, 2021 to 2036
Table 127: Rest of Latin America Influenza Vaccine Market Value (US$ Bn) Forecast, by Valency, 2021 to 2036
Table 128: Rest of Latin America Influenza Vaccine Market Value (US$ Bn) Forecast, by Age Group, 2021 to 2036
Table 129: Rest of Latin America Influenza Vaccine Market Value (US$ Bn) Forecast, by Route of Administration, 2021 to 2036
Table 130: Rest of Latin America Influenza Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2021 to 2036
Table 131: Middle East and Africa Influenza Vaccine Market Value (US$ Bn) Forecast, by Type, 2021 to 2036
Table 132: Middle East and Africa Influenza Vaccine Market Value (US$ Bn) Forecast, by Valency, 2021 to 2036
Table 133: Middle East and Africa Influenza Vaccine Market Value (US$ Bn) Forecast, by Age Group, 2021 to 2036
Table 134: Middle East and Africa Influenza Vaccine Market Value (US$ Bn) Forecast, by Route of Administration, 2021 to 2036
Table 135: Middle East and Africa Influenza Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2021 to 2036
Table 136: Middle East and Africa Influenza Vaccine Market Value (US$ Bn) Forecast, by Country/Sub-region, 2021 to 2036
Table 137: GCC Countries Influenza Vaccine Market Value (US$ Bn) Forecast, by Type, 2021 to 2036
Table 138: GCC Countries Influenza Vaccine Market Value (US$ Bn) Forecast, by Valency, 2021 to 2036
Table 139: GCC Countries Influenza Vaccine Market Value (US$ Bn) Forecast, by Age Group, 2021 to 2036
Table 140: GCC Countries Influenza Vaccine Market Value (US$ Bn) Forecast, by Route of Administration, 2021 to 2036
Table 141: GCC Countries Influenza Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2021 to 2036
Table 142: South Africa Influenza Vaccine Market Value (US$ Bn) Forecast, by Type, 2021 to 2036
Table 143: South Africa Influenza Vaccine Market Value (US$ Bn) Forecast, by Valency, 2021 to 2036
Table 144: South Africa Influenza Vaccine Market Value (US$ Bn) Forecast, by Age Group, 2021 to 2036
Table 145: South Africa Influenza Vaccine Market Value (US$ Bn) Forecast, by Route of Administration, 2021 to 2036
Table 146: South Africa Influenza Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2021 to 2036
Table 147: Rest of Middle East and Africa Influenza Vaccine Market Value (US$ Bn) Forecast, by Type, 2021 to 2036
Table 148: Rest of Middle East and Africa Influenza Vaccine Market Value (US$ Bn) Forecast, by Valency, 2021 to 2036
Table 149: Rest of Middle East and Africa Influenza Vaccine Market Value (US$ Bn) Forecast, by Age Group, 2021 to 2036
Table 150: Rest of Middle East and Africa Influenza Vaccine Market Value (US$ Bn) Forecast, by Route of Administration, 2021 to 2036
Table 151: Rest of Middle East and Africa Influenza Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2021 to 2036

List of Figures

Figure 01: Global Influenza Vaccine Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 02: Global Influenza Vaccine Market Value Share Analysis, by Type, 2025 and 2036
Figure 03: Global Influenza Vaccine Market Attractiveness Analysis, by Type, 2026 to 2036
Figure 04: Global Influenza Vaccine Market Revenue (US$ Bn), by Inactivated, 2021 to 2036
Figure 05: Global Influenza Vaccine Market Revenue (US$ Bn), by Live Attenuated, 2021 to 2036
Figure 06: Global Influenza Vaccine Market Value Share Analysis, by Valency, 2025 and 2036
Figure 07: Global Influenza Vaccine Market Attractiveness Analysis, by Valency, 2026 to 2036
Figure 08: Global Influenza Vaccine Market Revenue (US$ Bn), by Quadrivalent, 2021 to 2036
Figure 09: Global Influenza Vaccine Market Revenue (US$ Bn), by Trivalent, 2021 to 2036
Figure 10: Global Influenza Vaccine Market Value Share Analysis, by Age Group, 2025 and 2036
Figure 11: Global Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2026 to 2036
Figure 12: Global Influenza Vaccine Market Revenue (US$ Bn), by Pediatric, 2021 to 2036
Figure 13: Global Influenza Vaccine Market Revenue (US$ Bn), by Adult, 2021 to 2036
Figure 14: Global Influenza Vaccine Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 15: Global Influenza Vaccine Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 16: Global Influenza Vaccine Market Revenue (US$ Bn), by Injection, 2021 to 2036
Figure 17: Global Influenza Vaccine Market Revenue (US$ Bn), by Nasal Spray, 2021 to 2036
Figure 18: Global Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 19: Global Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 20: Global Influenza Vaccine Market Revenue (US$ Bn), by Hospitals & Pharmacies, 2021 to 2036
Figure 21: Global Influenza Vaccine Market Revenue (US$ Bn), by Government & Institutional Supply, 2021 to 2036
Figure 22: Global Influenza Vaccine Market Revenue (US$ Bn), by Others, 2021 to 2036
Figure 23: Global Influenza Vaccine Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 24: Global Influenza Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 25: North America Influenza Vaccine Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 26: North America Influenza Vaccine Market Value Share Analysis, by Type, 2025 and 2036
Figure 27: North America Influenza Vaccine Market Attractiveness Analysis, by Type, 2026 to 2036
Figure 28: North America Influenza Vaccine Market Value Share Analysis, by Valency, 2025 and 2036
Figure 29: North America Influenza Vaccine Market Attractiveness Analysis, by Valency, 2026 to 2036
Figure 30: North America Influenza Vaccine Market Value Share Analysis, by Age Group, 2025 and 2036
Figure 31: North America Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2026 to 2036
Figure 32: North America Influenza Vaccine Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 33: North America Influenza Vaccine Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 34: North America Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 35: North America Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 36: North America Influenza Vaccine Market Value Share Analysis, by Country, 2025 and 2036
Figure 37: North America Influenza Vaccine Market Attractiveness Analysis, by Country, 2026 to 2036
Figure 38: U.S. Influenza Vaccine Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 39: U.S. Influenza Vaccine Market Value Share Analysis, by Type, 2025 and 2036
Figure 40: U.S. Influenza Vaccine Market Attractiveness Analysis, by Type, 2026 to 2036
Figure 41: U.S. Influenza Vaccine Market Value Share Analysis, by Valency, 2025 and 2036
Figure 42: U.S. Influenza Vaccine Market Attractiveness Analysis, by Valency, 2026 to 2036
Figure 43: U.S. Influenza Vaccine Market Value Share Analysis, by Age Group, 2025 and 2036
Figure 44: U.S. Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2026 to 2036
Figure 45: U.S. Influenza Vaccine Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 46: U.S. Influenza Vaccine Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 47: U.S. Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 48: U.S. Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 49: Canada Influenza Vaccine Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 50: Canada Influenza Vaccine Market Value Share Analysis, by Type, 2025 and 2036
Figure 51: Canada Influenza Vaccine Market Attractiveness Analysis, by Type, 2026 to 2036
Figure 52: Canada Influenza Vaccine Market Value Share Analysis, by Valency, 2025 and 2036
Figure 53: Canada Influenza Vaccine Market Attractiveness Analysis, by Valency, 2026 to 2036
Figure 54: Canada Influenza Vaccine Market Value Share Analysis, by Age Group, 2025 and 2036
Figure 55: Canada Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2026 to 2036
Figure 56: Canada Influenza Vaccine Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 57: Canada Influenza Vaccine Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 58: Canada Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 59: Canada Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 60: Europe Influenza Vaccine Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 61: Europe Influenza Vaccine Market Value Share Analysis, by Type, 2025 and 2036
Figure 62: Europe Influenza Vaccine Market Attractiveness Analysis, by Type, 2026 to 2036
Figure 63: Europe Influenza Vaccine Market Value Share Analysis, by Valency, 2025 and 2036
Figure 64: Europe Influenza Vaccine Market Attractiveness Analysis, by Valency, 2026 to 2036
Figure 65: Europe Influenza Vaccine Market Value Share Analysis, by Age Group, 2025 and 2036
Figure 66: Europe Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2026 to 2036
Figure 67: Europe Influenza Vaccine Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 68: Europe Influenza Vaccine Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 69: Europe Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 70: Europe Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 71: Europe Influenza Vaccine Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 72: Europe Influenza Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 73: Germany Influenza Vaccine Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 74: Germany Influenza Vaccine Market Value Share Analysis, by Type, 2025 and 2036
Figure 75: Germany Influenza Vaccine Market Attractiveness Analysis, by Type, 2026 to 2036
Figure 76: Germany Influenza Vaccine Market Value Share Analysis, by Valency, 2025 and 2036
Figure 77: Germany Influenza Vaccine Market Attractiveness Analysis, by Valency, 2026 to 2036
Figure 78: Germany Influenza Vaccine Market Value Share Analysis, by Age Group, 2025 and 2036
Figure 79: Germany Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2026 to 2036
Figure 80: Germany Influenza Vaccine Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 81: Germany Influenza Vaccine Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 82: Germany Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 83: Germany Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 84: U.K. Influenza Vaccine Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 85: U.K. Influenza Vaccine Market Value Share Analysis, by Type, 2025 and 2036
Figure 86: U.K. Influenza Vaccine Market Attractiveness Analysis, by Type, 2026 to 2036
Figure 87: U.K. Influenza Vaccine Market Value Share Analysis, by Valency, 2025 and 2036
Figure 88: U.K. Influenza Vaccine Market Attractiveness Analysis, by Valency, 2026 to 2036
Figure 89: U.K. Influenza Vaccine Market Value Share Analysis, by Age Group, 2025 and 2036
Figure 90: U.K. Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2026 to 2036
Figure 91: U.K. Influenza Vaccine Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 92: U.K. Influenza Vaccine Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 93: U.K. Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 94: U.K. Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 95: France Influenza Vaccine Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 96: France Influenza Vaccine Market Value Share Analysis, by Type, 2025 and 2036
Figure 97: France Influenza Vaccine Market Attractiveness Analysis, by Type, 2026 to 2036
Figure 98: France Influenza Vaccine Market Value Share Analysis, by Valency, 2025 and 2036
Figure 99: France Influenza Vaccine Market Attractiveness Analysis, by Valency, 2026 to 2036
Figure 100: France Influenza Vaccine Market Value Share Analysis, by Age Group, 2025 and 2036
Figure 101: France Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2026 to 2036
Figure 102: France Influenza Vaccine Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 103: France Influenza Vaccine Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 104: France Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 105: France Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 106: Italy Influenza Vaccine Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 107: Italy Influenza Vaccine Market Value Share Analysis, by Type, 2025 and 2036
Figure 108: Italy Influenza Vaccine Market Attractiveness Analysis, by Type, 2026 to 2036
Figure 109: Italy Influenza Vaccine Market Value Share Analysis, by Valency, 2025 and 2036
Figure 110: Italy Influenza Vaccine Market Attractiveness Analysis, by Valency, 2026 to 2036
Figure 111: Italy Influenza Vaccine Market Value Share Analysis, by Age Group, 2025 and 2036
Figure 112: Italy Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2026 to 2036
Figure 113: Italy Influenza Vaccine Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 114: Italy Influenza Vaccine Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 115: Italy Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 116: Italy Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 117: Spain Influenza Vaccine Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 118: Spain Influenza Vaccine Market Value Share Analysis, by Type, 2025 and 2036
Figure 119: Spain Influenza Vaccine Market Attractiveness Analysis, by Type, 2026 to 2036
Figure 120: Spain Influenza Vaccine Market Value Share Analysis, by Valency, 2025 and 2036
Figure 121: Spain Influenza Vaccine Market Attractiveness Analysis, by Valency, 2026 to 2036
Figure 122: Spain Influenza Vaccine Market Value Share Analysis, by Age Group, 2025 and 2036
Figure 123: Spain Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2026 to 2036
Figure 124: Spain Influenza Vaccine Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 125: Spain Influenza Vaccine Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 126: Spain Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 127: Spain Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 128: The Netherlands Influenza Vaccine Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 129: The Netherlands Influenza Vaccine Market Value Share Analysis, by Type, 2025 and 2036
Figure 130: The Netherlands Influenza Vaccine Market Attractiveness Analysis, by Type, 2026 to 2036
Figure 131: The Netherlands Influenza Vaccine Market Value Share Analysis, by Valency, 2025 and 2036
Figure 132: The Netherlands Influenza Vaccine Market Attractiveness Analysis, by Valency, 2026 to 2036
Figure 133: The Netherlands Influenza Vaccine Market Value Share Analysis, by Age Group, 2025 and 2036
Figure 134: The Netherlands Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2026 to 2036
Figure 135: The Netherlands Influenza Vaccine Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 136: The Netherlands Influenza Vaccine Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 137: The Netherlands Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 138: The Netherlands Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 139: Rest of Europe Influenza Vaccine Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 140: Rest of Europe Influenza Vaccine Market Value Share Analysis, by Type, 2025 and 2036
Figure 141: Rest of Europe Influenza Vaccine Market Attractiveness Analysis, by Type, 2026 to 2036
Figure 142: Rest of Europe Influenza Vaccine Market Value Share Analysis, by Valency, 2025 and 2036
Figure 143: Rest of Europe Influenza Vaccine Market Attractiveness Analysis, by Valency, 2026 to 2036
Figure 144: Rest of Europe Influenza Vaccine Market Value Share Analysis, by Age Group, 2025 and 2036
Figure 145: Rest of Europe Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2026 to 2036
Figure 146: Rest of Europe Influenza Vaccine Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 147: Rest of Europe Influenza Vaccine Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 148: Rest of Europe Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 149: Rest of Europe Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 150: Asia Pacific Influenza Vaccine Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 151: Asia Pacific Influenza Vaccine Market Value Share Analysis, by Type, 2025 and 2036
Figure 152: Asia Pacific Influenza Vaccine Market Attractiveness Analysis, by Type, 2026 to 2036
Figure 153: Asia Pacific Influenza Vaccine Market Value Share Analysis, by Valency, 2025 and 2036
Figure 154: Asia Pacific Influenza Vaccine Market Attractiveness Analysis, by Valency, 2026 to 2036
Figure 155: Asia Pacific Influenza Vaccine Market Value Share Analysis, by Age Group, 2025 and 2036
Figure 156: Asia Pacific Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2026 to 2036
Figure 157: Asia Pacific Influenza Vaccine Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 158: Asia Pacific Influenza Vaccine Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 159: Asia Pacific Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 160: Asia Pacific Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 161: Asia Pacific Influenza Vaccine Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 162: Asia Pacific Influenza Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 163: China Influenza Vaccine Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 164: China Influenza Vaccine Market Value Share Analysis, by Type, 2025 and 2036
Figure 165: China Influenza Vaccine Market Attractiveness Analysis, by Type, 2026 to 2036
Figure 166: China Influenza Vaccine Market Value Share Analysis, by Valency, 2025 and 2036
Figure 167: China Influenza Vaccine Market Attractiveness Analysis, by Valency, 2026 to 2036
Figure 168: China Influenza Vaccine Market Value Share Analysis, by Age Group, 2025 and 2036
Figure 169: China Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2026 to 2036
Figure 170: China Influenza Vaccine Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 171: China Influenza Vaccine Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 172: China Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 173: China Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 174: Japan Influenza Vaccine Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 175: Japan Influenza Vaccine Market Value Share Analysis, by Type, 2025 and 2036
Figure 176: Japan Influenza Vaccine Market Attractiveness Analysis, by Type, 2026 to 2036
Figure 177: Japan Influenza Vaccine Market Value Share Analysis, by Valency, 2025 and 2036
Figure 178: Japan Influenza Vaccine Market Attractiveness Analysis, by Valency, 2026 to 2036
Figure 179: Japan Influenza Vaccine Market Value Share Analysis, by Age Group, 2025 and 2036
Figure 180: Japan Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2026 to 2036
Figure 181: Japan Influenza Vaccine Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 182: Japan Influenza Vaccine Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 183: Japan Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 184: Japan Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 185: India Influenza Vaccine Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 186: India Influenza Vaccine Market Value Share Analysis, by Type, 2025 and 2036
Figure 187: India Influenza Vaccine Market Attractiveness Analysis, by Type, 2026 to 2036
Figure 188: India Influenza Vaccine Market Value Share Analysis, by Valency, 2025 and 2036
Figure 189: India Influenza Vaccine Market Attractiveness Analysis, by Valency, 2026 to 2036
Figure 190: India Influenza Vaccine Market Value Share Analysis, by Age Group, 2025 and 2036
Figure 191: India Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2026 to 2036
Figure 192: India Influenza Vaccine Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 193: India Influenza Vaccine Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 194: India Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 195: India Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 196: South Korea Influenza Vaccine Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 197: South Korea Influenza Vaccine Market Value Share Analysis, by Type, 2025 and 2036
Figure 198: South Korea Influenza Vaccine Market Attractiveness Analysis, by Type, 2026 to 2036
Figure 199: South Korea Influenza Vaccine Market Value Share Analysis, by Valency, 2025 and 2036
Figure 200: South Korea Influenza Vaccine Market Attractiveness Analysis, by Valency, 2026 to 2036
Figure 201: South Korea Influenza Vaccine Market Value Share Analysis, by Age Group, 2025 and 2036
Figure 202: South Korea Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2026 to 2036
Figure 203: South Korea Influenza Vaccine Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 204: South Korea Influenza Vaccine Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 205: South Korea Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 206: South Korea Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 207: Australia Influenza Vaccine Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 208: Australia Influenza Vaccine Market Value Share Analysis, by Type, 2025 and 2036
Figure 209: Australia Influenza Vaccine Market Attractiveness Analysis, by Type, 2026 to 2036
Figure 210: Australia Influenza Vaccine Market Value Share Analysis, by Valency, 2025 and 2036
Figure 211: Australia Influenza Vaccine Market Attractiveness Analysis, by Valency, 2026 to 2036
Figure 212: Australia Influenza Vaccine Market Value Share Analysis, by Age Group, 2025 and 2036
Figure 213: Australia Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2026 to 2036
Figure 214: Australia Influenza Vaccine Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 215: Australia Influenza Vaccine Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 216: Australia Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 217: Australia Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 218: ASEAN Influenza Vaccine Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 219: ASEAN Influenza Vaccine Market Value Share Analysis, by Type, 2025 and 2036
Figure 220: ASEAN Influenza Vaccine Market Attractiveness Analysis, by Type, 2026 to 2036
Figure 221: ASEAN Influenza Vaccine Market Value Share Analysis, by Valency, 2025 and 2036
Figure 222: ASEAN Influenza Vaccine Market Attractiveness Analysis, by Valency, 2026 to 2036
Figure 223: ASEAN Influenza Vaccine Market Value Share Analysis, by Age Group, 2025 and 2036
Figure 224: ASEAN Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2026 to 2036
Figure 225: ASEAN Influenza Vaccine Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 226: ASEAN Influenza Vaccine Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 227: ASEAN Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 228: ASEAN Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 229: Rest of Asia Pacific Influenza Vaccine Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 230: Rest of Asia Pacific Influenza Vaccine Market Value Share Analysis, by Type, 2025 and 2036
Figure 231: Rest of Asia Pacific Influenza Vaccine Market Attractiveness Analysis, by Type, 2026 to 2036
Figure 232: Rest of Asia Pacific Influenza Vaccine Market Value Share Analysis, by Valency, 2025 and 2036
Figure 233: Rest of Asia Pacific Influenza Vaccine Market Attractiveness Analysis, by Valency, 2026 to 2036
Figure 234: Rest of Asia Pacific Influenza Vaccine Market Value Share Analysis, by Age Group, 2025 and 2036
Figure 235: Rest of Asia Pacific Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2026 to 2036
Figure 236: Rest of Asia Pacific Influenza Vaccine Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 237: Rest of Asia Pacific Influenza Vaccine Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 238: Rest of Asia Pacific Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 239: Rest of Asia Pacific Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 240: Latin America Influenza Vaccine Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 241: Latin America Influenza Vaccine Market Value Share Analysis, by Type, 2025 and 2036
Figure 242: Latin America Influenza Vaccine Market Attractiveness Analysis, by Type, 2026 to 2036
Figure 243: Latin America Influenza Vaccine Market Value Share Analysis, by Valency, 2025 and 2036
Figure 244: Latin America Influenza Vaccine Market Attractiveness Analysis, by Valency, 2026 to 2036
Figure 245: Latin America Influenza Vaccine Market Value Share Analysis, by Age Group, 2025 and 2036
Figure 246: Latin America Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2026 to 2036
Figure 247: Latin America Influenza Vaccine Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 248: Latin America Influenza Vaccine Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 249: Latin America Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 250: Latin America Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 251: Latin America Influenza Vaccine Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 252: Latin America Influenza Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 253: Brazil Influenza Vaccine Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 254: Brazil Influenza Vaccine Market Value Share Analysis, by Type, 2025 and 2036
Figure 255: Brazil Influenza Vaccine Market Attractiveness Analysis, by Type, 2026 to 2036
Figure 256: Brazil Influenza Vaccine Market Value Share Analysis, by Valency, 2025 and 2036
Figure 257: Brazil Influenza Vaccine Market Attractiveness Analysis, by Valency, 2026 to 2036
Figure 258: Brazil Influenza Vaccine Market Value Share Analysis, by Age Group, 2025 and 2036
Figure 259: Brazil Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2026 to 2036
Figure 260: Brazil Influenza Vaccine Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 261: Brazil Influenza Vaccine Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 262: Brazil Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 263: Brazil Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 264: Mexico Influenza Vaccine Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 265: Mexico Influenza Vaccine Market Value Share Analysis, by Type, 2025 and 2036
Figure 266: Mexico Influenza Vaccine Market Attractiveness Analysis, by Type, 2026 to 2036
Figure 267: Mexico Influenza Vaccine Market Value Share Analysis, by Valency, 2025 and 2036
Figure 268: Mexico Influenza Vaccine Market Attractiveness Analysis, by Valency, 2026 to 2036
Figure 269: Mexico Influenza Vaccine Market Value Share Analysis, by Age Group, 2025 and 2036
Figure 270: Mexico Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2026 to 2036
Figure 271: Mexico Influenza Vaccine Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 272: Mexico Influenza Vaccine Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 273: Mexico Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 274: Mexico Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 275: Argentina Influenza Vaccine Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 276: Argentina Influenza Vaccine Market Value Share Analysis, by Type, 2025 and 2036
Figure 277: Argentina Influenza Vaccine Market Attractiveness Analysis, by Type, 2026 to 2036
Figure 278: Argentina Influenza Vaccine Market Value Share Analysis, by Valency, 2025 and 2036
Figure 279: Argentina Influenza Vaccine Market Attractiveness Analysis, by Valency, 2026 to 2036
Figure 280: Argentina Influenza Vaccine Market Value Share Analysis, by Age Group, 2025 and 2036
Figure 281: Argentina Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2026 to 2036
Figure 282: Argentina Influenza Vaccine Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 283: Argentina Influenza Vaccine Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 284: Argentina Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 285: Argentina Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 286: Rest of Latin America Influenza Vaccine Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 287: Rest of Latin America Influenza Vaccine Market Value Share Analysis, by Type, 2025 and 2036
Figure 288: Rest of Latin America Influenza Vaccine Market Attractiveness Analysis, by Type, 2026 to 2036
Figure 289: Rest of Latin America Influenza Vaccine Market Value Share Analysis, by Valency, 2025 and 2036
Figure 290: Rest of Latin America Influenza Vaccine Market Attractiveness Analysis, by Valency, 2026 to 2036
Figure 291: Rest of Latin America Influenza Vaccine Market Value Share Analysis, by Age Group, 2025 and 2036
Figure 292: Rest of Latin America Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2026 to 2036
Figure 293: Rest of Latin America Influenza Vaccine Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 294: Rest of Latin America Influenza Vaccine Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 295: Rest of Latin America Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 296: Rest of Latin America Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 297: Middle East and Africa Influenza Vaccine Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 298: Middle East and Africa Influenza Vaccine Market Value Share Analysis, by Type, 2025 and 2036
Figure 299: Middle East and Africa Influenza Vaccine Market Attractiveness Analysis, by Type, 2026 to 2036
Figure 300: Middle East and Africa Influenza Vaccine Market Value Share Analysis, by Valency, 2025 and 2036
Figure 301: Middle East and Africa Influenza Vaccine Market Attractiveness Analysis, by Valency, 2026 to 2036
Figure 302: Middle East and Africa Influenza Vaccine Market Value Share Analysis, by Age Group, 2025 and 2036
Figure 303: Middle East and Africa Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2026 to 2036
Figure 304: Middle East and Africa Influenza Vaccine Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 305: Middle East and Africa Influenza Vaccine Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 306: Middle East and Africa Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 307: Middle East and Africa Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 308: Middle East and Africa Influenza Vaccine Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 309: Middle East and Africa Influenza Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 310: GCC Countries Influenza Vaccine Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 311: GCC Countries Influenza Vaccine Market Value Share Analysis, by Type, 2025 and 2036
Figure 312: GCC Countries Influenza Vaccine Market Attractiveness Analysis, by Type, 2026 to 2036
Figure 313: GCC Countries Influenza Vaccine Market Value Share Analysis, by Valency, 2025 and 2036
Figure 314: GCC Countries Influenza Vaccine Market Attractiveness Analysis, by Valency, 2026 to 2036
Figure 315: GCC Countries Influenza Vaccine Market Value Share Analysis, by Age Group, 2025 and 2036
Figure 316: GCC Countries Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2026 to 2036
Figure 317: GCC Countries Influenza Vaccine Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 318: GCC Countries Influenza Vaccine Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 319: GCC Countries Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 320: GCC Countries Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 321: South Africa Influenza Vaccine Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 322: South Africa Influenza Vaccine Market Value Share Analysis, by Type, 2025 and 2036
Figure 323: South Africa Influenza Vaccine Market Attractiveness Analysis, by Type, 2026 to 2036
Figure 324: South Africa Influenza Vaccine Market Value Share Analysis, by Valency, 2025 and 2036
Figure 325: South Africa Influenza Vaccine Market Attractiveness Analysis, by Valency, 2026 to 2036
Figure 326: South Africa Influenza Vaccine Market Value Share Analysis, by Age Group, 2025 and 2036
Figure 327: South Africa Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2026 to 2036
Figure 328: South Africa Influenza Vaccine Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 329: South Africa Influenza Vaccine Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 330: South Africa Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 331: South Africa Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 332: Rest of Middle East and Africa Influenza Vaccine Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 333: Rest of Middle East and Africa Influenza Vaccine Market Value Share Analysis, by Type, 2025 and 2036
Figure 334: Rest of Middle East and Africa Influenza Vaccine Market Attractiveness Analysis, by Type, 2026 to 2036
Figure 335: Rest of Middle East and Africa Influenza Vaccine Market Value Share Analysis, by Valency, 2025 and 2036
Figure 336: Rest of Middle East and Africa Influenza Vaccine Market Attractiveness Analysis, by Valency, 2026 to 2036
Figure 337: Rest of Middle East and Africa Influenza Vaccine Market Value Share Analysis, by Age Group, 2025 and 2036
Figure 338: Rest of Middle East and Africa Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2026 to 2036
Figure 339: Rest of Middle East and Africa Influenza Vaccine Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 340: Rest of Middle East and Africa Influenza Vaccine Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 341: Rest of Middle East and Africa Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 342: Rest of Middle East and Africa Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036